Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients

Clinical trial NCT04976127 · TERMINATED

Trial details

NCT number: NCT04976127
Sponsor: InnoMedica Schweiz AG
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2021-12-11
Primary completion: 2025-08-06
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.